IVF provider Virtus Health's share price is up 17% since Australia's 9,000 missing babies from 6 Apr 16 (Buy – $6.22) and has risen 60% since August last year. The stock now sports a price-earnings ratio of 17 based on 2016 estimates, and a dividend yield of 3.8%. Virtus has plenty of free cash flow and decent growth prospects, but having moved above our recommended Buy price, we're downgrading to HOLD.
Note: The Intelligent Investor Growth Portfolio and Equity Income Portfolio own shares in Virtus Health. You can find out about investing directly in Intelligent Investor and InvestSMART portfolios by clicking here.